BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

274 related articles for article (PubMed ID: 22396005)

  • 1. Preoperative imaging of colorectal liver metastases after neoadjuvant chemotherapy: a meta-analysis.
    van Kessel CS; Buckens CF; van den Bosch MA; van Leeuwen MS; van Hillegersberg R; Verkooijen HM
    Ann Surg Oncol; 2012 Sep; 19(9):2805-13. PubMed ID: 22396005
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diagnostic imaging of colorectal liver metastases with CT, MR imaging, FDG PET, and/or FDG PET/CT: a meta-analysis of prospective studies including patients who have not previously undergone treatment.
    Niekel MC; Bipat S; Stoker J
    Radiology; 2010 Dec; 257(3):674-84. PubMed ID: 20829538
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role and limitations of 18-fluoro-2-deoxy-D-glucose positron emission tomography (FDG-PET) scan and computerized tomography (CT) in restaging patients with hepatic colorectal metastases following neoadjuvant chemotherapy: comparison with operative and pathological findings.
    Lubezky N; Metser U; Geva R; Nakache R; Shmueli E; Klausner JM; Even-Sapir E; Figer A; Ben-Haim M
    J Gastrointest Surg; 2007 Apr; 11(4):472-8. PubMed ID: 17436132
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diagnostic accuracy of CE-CT, MRI and FDG PET/CT for detecting colorectal cancer liver metastases in patients considered eligible for hepatic resection and/or local ablation.
    Sivesgaard K; Larsen LP; Sørensen M; Kramer S; Schlander S; Amanavicius N; Bharadwaz A; Tønner Nielsen D; Viborg Mortensen F; Morre Pedersen E
    Eur Radiol; 2018 Nov; 28(11):4735-4747. PubMed ID: 29736846
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The diagnostic performance of
    Samim M; Molenaar IQ; Seesing MFJ; van Rossum PSN; van den Bosch MAAJ; Ruers TJM; Borel Rinkes IHM; van Hillegersberg R; Lam MGEH; Verkooijen HM
    Surg Oncol; 2017 Mar; 26(1):37-45. PubMed ID: 28317583
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diagnostic performance of CT, gadoxetate disodium-enhanced MRI, and PET/CT for the diagnosis of colorectal liver metastasis: Systematic review and meta-analysis.
    Choi SH; Kim SY; Park SH; Kim KW; Lee JY; Lee SS; Lee MG
    J Magn Reson Imaging; 2018 May; 47(5):1237-1250. PubMed ID: 28901685
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Imaging of colorectal cancer liver metastases using contrast-enhanced US, multidetector CT, MRI, and FDG PET/CT: a meta-analysis.
    Tsili AC; Alexiou G; Naka C; Argyropoulou MI
    Acta Radiol; 2021 Mar; 62(3):302-312. PubMed ID: 32506935
    [TBL] [Abstract][Full Text] [Related]  

  • 8. FDG-PET/CT and MRI for Evaluation of Pathologic Response to Neoadjuvant Chemotherapy in Patients With Breast Cancer: A Meta-Analysis of Diagnostic Accuracy Studies.
    Sheikhbahaei S; Trahan TJ; Xiao J; Taghipour M; Mena E; Connolly RM; Subramaniam RM
    Oncologist; 2016 Aug; 21(8):931-9. PubMed ID: 27401897
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Colorectal liver metastases: CT, MR imaging, and PET for diagnosis--meta-analysis.
    Bipat S; van Leeuwen MS; Comans EF; Pijl ME; Bossuyt PM; Zwinderman AH; Stoker J
    Radiology; 2005 Oct; 237(1):123-31. PubMed ID: 16100087
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Utility of 18F-FDG PET and contrast-enhanced CT scan in the assessment of residual liver metastasis from colorectal cancer following adjuvant chemotherapy.
    Carnaghi C; Tronconi MC; Rimassa L; Tondulli L; Zuradelli M; Rodari M; Doci R; Luttmann F; Torzilli G; Rubello D; Al-Nahhas A; Santoro A; Chiti A
    Nucl Med Rev Cent East Eur; 2007; 10(1):12-5. PubMed ID: 17694495
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The use of PET-MRI in the follow-up after radiofrequency- and microwave ablation of colorectal liver metastases.
    Nielsen K; Scheffer HJ; Pieters IC; van Tilborg AA; van Waesberghe JH; Oprea-Lager DE; Meijerink MR; Kazemier G; Hoekstra OS; Schreurs HW; Sietses C; Meijer S; Comans EF; van den Tol PM
    BMC Med Imaging; 2014 Aug; 14():27. PubMed ID: 25103913
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diagnostic performance of CT, MRI and PET/CT in patients with suspected colorectal liver metastases: the superiority of MRI.
    Schulz A; Viktil E; Godt JC; Johansen CK; Dormagen JB; Holtedahl JE; Labori KJ; Bach-Gansmo T; Kløw NE
    Acta Radiol; 2016 Sep; 57(9):1040-8. PubMed ID: 26622057
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Controversies in the management of colorectal liver metastases: role of PET and PET/CT.
    Wiering B; Vogel WV; Ruers TJ; Oyen WJ
    Dig Surg; 2008; 25(6):413-20. PubMed ID: 19212113
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neoadjuvant chemotherapy affects staging of colorectal liver metastasis--a comparison of PET, CT and intraoperative ultrasound.
    Spatz J; Holl G; Sciuk J; Anthuber M; Arnholdt HM; Märkl B
    Int J Colorectal Dis; 2011 Feb; 26(2):165-71. PubMed ID: 20960208
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diagnostic accuracy and impact on management of (18)F-FDG PET and PET/CT in colorectal liver metastasis: a meta-analysis and systematic review.
    Maffione AM; Lopci E; Bluemel C; Giammarile F; Herrmann K; Rubello D
    Eur J Nucl Med Mol Imaging; 2015 Jan; 42(1):152-63. PubMed ID: 25319712
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Resection of liver metastases from colorectal cancer: does preoperative chemotherapy affect the accuracy of PET in preoperative planning?
    Adie S; Yip C; Chu F; Morris DL
    ANZ J Surg; 2009 May; 79(5):358-61. PubMed ID: 19566517
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assessment of liver metastases from colorectal adenocarcinoma following chemotherapy: SPIO-MRI versus FDG-PET/CT.
    Bacigalupo L; Aufort S; Eberlé MC; Assenat E; Ychou M; Gallix B
    Radiol Med; 2010 Oct; 115(7):1087-100. PubMed ID: 20574703
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The impact of fluor-18-deoxyglucose-positron emission tomography in the management of colorectal liver metastases.
    Wiering B; Krabbe PF; Jager GJ; Oyen WJ; Ruers TJ
    Cancer; 2005 Dec; 104(12):2658-70. PubMed ID: 16315241
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 18F-FDG PET/CT and PET for evaluation of pathological response to neoadjuvant chemotherapy in breast cancer: a meta-analysis.
    Cheng X; Li Y; Liu B; Xu Z; Bao L; Wang J
    Acta Radiol; 2012 Jul; 53(6):615-27. PubMed ID: 22734080
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Detection and Viability of Colorectal Liver Metastases After Neoadjuvant Chemotherapy: A Multiparametric PET/CT-MRI Study.
    Dunet V; Halkic N; Prior JO; Anaye A; Meuli RA; Sempoux C; Denys A; Schmidt S
    Clin Nucl Med; 2017 Apr; 42(4):258-263. PubMed ID: 28166142
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.